Clinical Trials Logo

Cocaine Use Disorders clinical trials

View clinical trials related to Cocaine Use Disorders.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT02680288 Recruiting - Clinical trials for Cocaine Use Disorders

Lorcaserin Intra Venous Cocaine Effects

LIVE
Start date: November 2015
Phase: Phase 1/Phase 2
Study type: Interventional

This is a randomized, cross-over, single-blind, placebo-controlled, single-center, multiple-panel evaluation of the potential for oral lorcaserin to modify cocaine self-administration in a laboratory setting. To prevent unauthorized drug use, study medications will be administered as participants are confined during overnight stays at the Medical Center. Non-treatment-seeking, regular cocaine users will receive oral treatment with single doses of placebo, lorcaserin 10 mg (Panel 1), or lorcaserin 20 mg (Panel 2). Afterwards, the subjective and reinforcing effects of intravenous cocaine will be measured in a laboratory setting.